Leela Barham asks why companies may choose to not submit their drugs to NICE and keep them off routine commissioning – a trend that appears to be on the rise. Appraisal of a treatment by the National ...
It’s fair to say that the topic of so-called ‘AI coding assistants’ is somewhat controversial. With arguments against them ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results